Cellebrite DI (NASDAQ:CLBT) Price Target Cut to $12.50 by Analysts at Needham & Company LLC
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Sat, 15 August 2026
What it is about
Thomas HoganShiven RamjiTowarzystwo Funduszy InwestycyjnychSecurities Exchange CommissionCellebrite Di Company ProfileNeedham CompanyFirst Horizon CorpAdvisory Services NetworkElevation Wealth Partners
Who published it, and when
How it spread - 1 original report
Sat, 15 August 2026
1 report- themarketsdaily.com08:45first to report
Cellebrite DI (NASDAQ:CLBT – Free Report) had its price objective cut by Needham & Company LLC from $15.00 to $12.50 in a research report sent to investors on Friday,Benzinga reports. They currently have a buy rating on the stock. Several other research firms have also issued reports on CLBT. Weiss Ratings upgraded Cellebrite DI from […]